In summary, our results suggest that ZNF692 upregulates c-Myc and CyclinA1 by activating EMT signaling pathway, promotes the proliferation and resistance to apoptosis of prostate cancer cells, and enhances cell invasion and migration. The gene discussed is MYC; the disease is Familial prostate cancer.